1. Home
  2. COCP vs WKSP Comparison

COCP vs WKSP Comparison

Compare COCP & WKSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COCP
  • WKSP
  • Stock Information
  • Founded
  • COCP 2006
  • WKSP 2003
  • Country
  • COCP United States
  • WKSP United States
  • Employees
  • COCP N/A
  • WKSP N/A
  • Industry
  • COCP Biotechnology: Pharmaceutical Preparations
  • WKSP Auto Parts:O.E.M.
  • Sector
  • COCP Health Care
  • WKSP Consumer Discretionary
  • Exchange
  • COCP Nasdaq
  • WKSP Nasdaq
  • Market Cap
  • COCP 15.5M
  • WKSP 14.6M
  • IPO Year
  • COCP N/A
  • WKSP N/A
  • Fundamental
  • Price
  • COCP $1.46
  • WKSP $3.47
  • Analyst Decision
  • COCP Strong Buy
  • WKSP Strong Buy
  • Analyst Count
  • COCP 1
  • WKSP 3
  • Target Price
  • COCP $6.00
  • WKSP $12.83
  • AVG Volume (30 Days)
  • COCP 29.6K
  • WKSP 536.3K
  • Earning Date
  • COCP 08-14-2025
  • WKSP 08-13-2025
  • Dividend Yield
  • COCP N/A
  • WKSP N/A
  • EPS Growth
  • COCP N/A
  • WKSP N/A
  • EPS
  • COCP N/A
  • WKSP N/A
  • Revenue
  • COCP N/A
  • WKSP $12,395,166.00
  • Revenue This Year
  • COCP N/A
  • WKSP $163.94
  • Revenue Next Year
  • COCP N/A
  • WKSP $78.39
  • P/E Ratio
  • COCP N/A
  • WKSP N/A
  • Revenue Growth
  • COCP N/A
  • WKSP 232.13
  • 52 Week Low
  • COCP $1.12
  • WKSP $2.44
  • 52 Week High
  • COCP $3.26
  • WKSP $12.00
  • Technical
  • Relative Strength Index (RSI)
  • COCP 38.13
  • WKSP 53.39
  • Support Level
  • COCP $1.37
  • WKSP $3.01
  • Resistance Level
  • COCP $1.60
  • WKSP $4.30
  • Average True Range (ATR)
  • COCP 0.09
  • WKSP 0.33
  • MACD
  • COCP -0.01
  • WKSP 0.06
  • Stochastic Oscillator
  • COCP 27.52
  • WKSP 45.61

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

About WKSP Worksport Ltd.

Worksport Ltd through its subsidiaries, designs, develops, manufactures, and owns the IP on a variety of tonneau covers, solar integrations, and NP (Non-Parasitic), Hydrogen-based true green energy solutions for the sustainable, clean energy, and automotive industries. The company's product includes soft vinyl tonneau covers and hard aluminum tonneau covers. It operates in two reporting segments for financial reporting purposes: Hard Tonneau Covers and Soft Tonneau Covers. Geographically, the company operates in Canada, United States and Other Countries.

Share on Social Networks: